Key takeaway
Two programs can both say they have a bed tonight. NIDA says no single treatment is right for everyone. The ASAM Criteria uses a six-part assessment to match the least intensive level of care that is still safe. A fixed 28-day stay is the wrong kind of plan. Compare medication, the setting, and the step after discharge.
Last updated: Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Two admissions offices can both say they have room tonight, and the photos can look like the same place. One may be a few counseling hours a week. Another may be a hospital bed with nurses. You are allowed to slow down. NIDA's research-based guide says no single treatment is appropriate for everyone, and that matching the setting and the services to the person's problems is what matters. A photo of a bedroom does not do that matching.
If withdrawal has already produced a seizure, severe confusion, or trouble breathing, call 911. Do not keep comparing websites. For a mental health crisis, call or text 988.
Start with the assessment, not the building
The ASAM Criteria is a national placement standard. ASAM says patients should receive a multidimensional assessment, and that the results should be used to match the least intensive level of care that is still safe. The public intake guide lists six dimensions:
- Acute intoxication and withdrawal potential
- Biomedical conditions and complications
- Emotional, behavioral, and cognitive conditions and complications
- Readiness to change
- Relapse, continued use, or continued problem potential
- Recovery/living environment
You do not have to score yourself. You can ask a program which dimensions drove its recommendation. A person with a history of alcohol withdrawal seizures is not in the same spot as a person whose main problem is a living room where other people are using. The first needs medical withdrawal care. The second may need a safer place to live plus outpatient treatment. SAMHSA's TIP 45 says detoxification can happen in many settings and that placement should match the patient's needs. It also says patients with a history of severe withdrawals are not good candidates for social detoxification. The detox guide quotes the fuller warning on seizures and delirium tremens. What the first days feel like is in the 72-hour guide.
Settings in plain language
NIDA describes outpatient treatment as varied. It costs less than residential or inpatient care and is often more suitable for people with jobs or extensive social support. The same passage warns that low-intensity programs may offer little more than drug education. Intensive day treatment, NIDA says, can be comparable to residential programs in services and effectiveness, depending on the person. Group counseling is common. Some outpatient programs also treat medical or mental health problems alongside the substance use disorder.
Residential and hospital care exist for people who need a higher intensity, including those who are not safe managing withdrawal at home. ASAM's point is not that the highest intensity is the best intensity. It says people should step toward less intensive services when they are progressing, and toward more intensive services when symptoms worsen. A program that offers only one rung is a poor match for someone whose needs will change.
ASAM also says addiction should be handled with a chronic-care model. It calls out benefits built around a predetermined length, such as a "28-day program," and says length should respond to progress. NIDA says individuals progress at different rates, so there is no predetermined length. It also says research has shown that good outcomes depend on adequate time in treatment. In that guide, participation in residential or outpatient treatment for less than 90 days is, in general, of limited effectiveness, and 12 months is considered the minimum for methadone maintenance, with some people benefiting for many years. Those are research summaries. They are not a warranty, and they are not a reason to buy a long stay you do not need.
Medication is part of the comparison
If opioids are the problem, ask whether methadone, buprenorphine, or naltrexone is available when a clinician recommends it. NIDA says these medicines help people stop or reduce opioid use and that methadone and buprenorphine are associated with a lower risk of death and overdose. Meetings do not replace that option. A program that requires you to stop a prescribed medicine in order to be admitted should explain the medical reason. "We don't believe in that" is not an assessment. Read the medication FAQ before you agree to stop.
For alcohol, ask what happens after withdrawal. Detoxification is not the treatment of the use disorder. For stimulants such as methamphetamine, NIDA's other pages note there is no FDA-approved medicine for the use disorder itself. Ask which behavioral therapies are actually on the schedule. The choosing-a-rehab guide covers license, accreditation, and those therapies. Do that check, then compare the level of care.
The living situation is a real dimension
ASAM's sixth dimension is the recovery environment. A clinically sound outpatient plan fails if you return each night to a place where drugs are in the house. That does not make a sober home into a hospital. Recovery housing is a support setting with its own standards, gaps, and red flags. The sober living guide covers NARR's levels and why a house should not ban prescribed medications.
If the safer program is in another state, settle payment and medicine transport before you buy a ticket. The flying guide covers that sequence.
Money, without a price list
What you owe depends on the plan, the network, and the level of care. There is no national price to copy here. Before you choose, ask what is authorized, what you pay if the insurer denies the stay, and whether a less intensive level was considered. A denial has an appeal path for many private plans. The appeals guide summarizes HealthCare.gov's clocks and points Medicare beneficiaries to Medicare's own rules. The insurance cost guide covers deductibles and parity. Neither guide promises that a plan will pay.
A short comparison you can write down
When two programs are both available tonight, write four answers for each:
- What level of care are you actually being offered, in words a clinician would use?
- Which assessment findings make that level necessary, rather than a lower one?
- Will prescribed medication for opioid or alcohol use disorder continue, and who is the prescriber?
- What is the planned step-down, and who arranges it before discharge?
If someone pushes a deposit and cannot answer those, slow down. FindTreatment.gov lets you see other facilities. Call or text (800) 653-9376 if you want help framing the questions.
Additional Resources
Sources cited on this page:
- NIDA: Principles of Drug Addiction Treatment (Research-Based Guide, Third Edition)
- ASAM: The ASAM Criteria
- ASAM: Criteria intake assessment guide (six dimensions)
- NIDA: Medications for Opioid Use Disorder
- SAMHSA TIP 45 quick guide: Detoxification and Substance Abuse Treatment
- SAMHSA FindTreatment.gov
- 988 Suicide & Crisis Lifeline
Common Questions
Should I pick the program with the first open bed?
An open bed at the wrong intensity can waste the crisis. ASAM says the goal is the least intensive level that is still safe, based on a full assessment, not on which brochure arrived first. Ask which needs drove the recommendation.
Is a 28-day stay the standard?
ASAM says some programs and payers design benefits around a predetermined length, such as a 28-day program, and that length should instead follow the person's progress. NIDA says there is no predetermined length, and that very short episodes are often of limited effectiveness. Neither statement promises that a longer stay will work.
Is outpatient always the weaker choice?
No. NIDA says outpatient care costs less than residential care and often suits people with jobs or strong social support. It also says some low-intensity programs offer little more than drug education, while intensive day treatment can match residential care for the right person.
What if one program bans the medicine another program prescribed?
Treat that as a clinical disagreement you should hear explained. NIDA describes methadone, buprenorphine, and naltrexone as effective treatments for opioid use disorder. A house rule is not a medical reason. Ask a clinician before you stop a prescribed medicine to get a bed.
Where do license and accreditation fit?
They are necessary checks, and they are a different comparison from level of care. Use the guide on choosing a rehab to verify a state license and to ask about Joint Commission or CARF accreditation. Accreditation does not promise an outcome.